Medicine
Naratriptan 2.5 mg tablet
Naratriptan 2.5 mg tablet is a generic prescription medicine for oral use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20º to 25ºC (68º to 77ºF).
Key facts
- Active ingredient (INN)
- Naratriptan
- Brand
- Sold under the generic name
- Strength
- 2.5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 500 tablets, 9 tablets and 7 more
- Manufacturers
- Avet PharmaceuticalsIndiaAsclemedBionpharmaHikma Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20º to 25ºC (68º to 77ºF).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N02CC02 Naratriptan
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 7 July 2010
- Identifiers
- RxCUI 311918, 314135DailyMed set ID 41c29652-32f8-48dc-9038-0e2195aa2084, 93b7e6c2-e6a7-4f6b-9ecd-62d6bb0a6dda, fd1944b3-8054-4faa-a82e-d818dfdd3875 +1NDC 23155-055, 69452-341, 0054-0279 +1Application ANDA200502, ANDA091441, ANDA090381
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet in 1 bottle | 23155-055-03 | Avet PharmaceuticalsIndia | 15 March 2011 |
| 500 tablet in 1 bottle | 23155-055-05 | Avet PharmaceuticalsIndia | 15 March 2011 |
| 9 tablet in 1 blister pack | 23155-055-19 | Avet PharmaceuticalsIndia | 15 March 2011 |
| 1 blister pack in 1 carton / 9 tablet, film coated in 1 blister pack | 69452-341-72 | Bionpharma | 11 April 2022 |
| 9 tablet in 1 bottle | 0054-0279-03 | Hikma Pharmaceuticals | 7 October 2010 |
| 9 tablet in 1 blister pack | 87063-288-09 | Asclemed | 7 August 2026 |
| 12 tablet in 1 bottle | 87063-288-12 | Asclemed | 7 August 2026 |
| 30 tablet in 1 bottle | 87063-288-30 | Asclemed | 7 August 2026 |
| 60 tablet in 1 bottle | 87063-288-60 | Asclemed | 7 August 2026 |
| 90 tablet in 1 bottle | 87063-288-90 | Asclemed | 7 August 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 10 February 1998 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Naratriptan
Clinical summary
Naratriptan is a serotonin-1b and serotonin-1d receptor agonist indicated for the acute treatment of migraine with or without aura in adults, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Naratriptan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about NaratriptanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Naratriptan prescribing information (Bionpharma) · U.S. National Library of Medicine, DailyMed
Need Naratriptan 2.5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.